Development and Validation of a New HPLC Bio Analytical Internal Standard Method for the Analysis of Two Immunology Drugs (Lamivudine and Dolutegravir) in Human Plasma

Authors

  • Dr.K.R.S. Prasad Department of Chemistry, K.L. University, Vaddeswaram, India Author
  • Dr.V.D.N. Kumar Abbaraju Dept of Chemistry, GIS, GITAM University, Vishakapatnam, AP, India. Author
  • Dr.K. Uma Maheswar A.P.J Abdul Kalam Campus, Rajiv Gandhi University of Knowledge Technologies, Ongole, AP, India Author
  • Chaitanya Darapureddy Department of Chemistry, K.L. University, Vaddeswaram, India Author
  • Dr.Phani RS CH Department of Chemistry, K.L. University, Vaddeswaram, India Author

DOI:

https://doi.org/10.61841/529zhk75

Keywords:

RP-HPLC, Internal Standard, Bio-analytical, ICH Guidelines, Lamivudine, Dolutegravir and Abacavir.

Abstract

Bioanalytical methods are useful for the quantitative analysis of drugs and their metabolites in 
biological fluids. Bio-analytical internal standards methods plays vital role in areas of human clinical 
pharmacology. The aim of this work is to development and validation of bio-analytical internal standard method for 
determination of two immunology drugs Lamivudine (LMVD) and Dolutegravir (DTGR) in plasma with Abacavir
(ABVR) drug as internal standard (IS). Liquid-liquid extraction with Diethyl ether and methanol in the ratio of 
50:50 (v/v) was used for the extraction of drugs from the biological matrix. The optimized chromatography 
conditions consist of Water, Acetonitrile and Methanol in the ratio of 40:25:35 (v/v) as a mobile phase with 
Ascentis, C18 Column (250 X 4.6 mm, 5μ) as stationery phase. Isocratic elution with 1.2 ml flow separates the
LMVD at 3.5 min, DTGR at 9.8 min and ABVR at 6.8 min. The method was validated as per ICH guidelines. The 
relative standard deviation (%RSD) were found to be <5%for precision studies. Hence the method was found to be 
suitable fort the analysis of LMVD and DTGR in spiked human plasma. 

Downloads

Download data is not yet available.

References

[1] Fox Z, Dragsted UB, Gerstoft J, et al. (2006). "A randomized trial to evaluate continuation versus

discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: The COLATE trial".

Antiviral Therapy. 11 (6): 761–70.

[2] Koziel MJ, Peters MG (2007). "Viral hepatitis in HIV infection". N Engl J Med. 356 (14): 1445–54.

[3] British national formulary: BNF 69 (69 ed.). British Medical Association. 2015. p. 429.

[4] "Dolutegravir Sodium". The American Society of Health-System Pharmacists. Retrieved 8 December 2017.

[5] GeethaSwarupa P., Lakshmana Rao K., Prasad K.R.S., Suresh Babu K. Development and validation of

stability indicating reversed phase high-pressure liquid chromatography method for simultaneous

estimation of metformin and empagliflozin in bulk and tablet dosage form, Asian Journal of

Pharmaceutical and Clinical Research, 2016,9,126-135

[6] Danavena Rambabu, B.Bhoomaiah, Phani.R.S.Ch, K Balamurali Krishna, Validated Rp - HPLC Method

for the Estimation of Zolmitriptan In Formulation Pharmacophore 2011, Vol. 2 (2), 150-155

[7] Athota R.V., Jagarlapudi S.K., Singampalli M.R. Stability indicating HPLC method for the simultaneous

quantification of aspirin and pravastatin in bulk and tablets: Method development and validation, 2017,

Journal of Applied Pharmaceutical Science, 7(3)48-56

[8] N.V. Krishna Reddy, Phani. R.S.Ch and R. Rameshraju Validated Rp-Hplc Method For The Estimation Of

Nateglinide In Formulation, IJRPC 2011, 1(1) 46-49

[9] Reddy P.S., Jagarlapudi V.S.K., SekharanC.B.Determination of edoxaban in bulk and in tablet dosage form

by stability indicating high-performance liquid chromatography, 2016, Pharmaceutical Sciences, 2016, 22,

(1) 35-41

[10] Phani R.S.C.H., Prasad K.R.S., Mallu U.R. New analytical HPLC method development and validation for

the simultaneous quantification of paritaprevirombitasvir and Ritonavirin spiked human plasma, Oriental

Journal of Chemistry, 2017, 33,(5)2363-2369

[11] Nekkala K., Shanmukha Kumar J.V., Ramachandran D.Analytical method development and validation for

the simultaneous estimation of Sofosbuvir and Velpatasvir drug product by reverse phase high performance

liquid chromatography method, Asian Journal of Pharmaceutical and Clinical Research, 2018,11(2) 164-

168

[12] B. Prasanthi, J. Vijaya Ratna, R. S. Ch. Phani, Development and validation of RP-HPLC method for

simultaneous estimation of rifampicin, isoniazid and pyrazinamide in human plasma, Journal of Analytical

Chemistry, 2015, 70(8)1015–1022

[13] R. S. Ch. Phani, K. R. S. Prasad, Useni Reddy Mallu, A study of new method development, validation, and

forced degradation for simultaneous analysis of Dapagliflozin and Saxagliptin in pharmaceutical dosage.

Der Pharma Chemica, 2017, 9(20): 96-103

[14] R. S. Ch. Phani, K. R. S. Prasad, Useni Reddy Mallu, New Bio analytical method development and

validation for the simultaneous estimation of Trifluridine and Tipiracil in spiked human plasma, Research

J. Pharm. and Tech. 2017, 10(12): 4264-4268

[15] R. S. Ch. Phani, K. R. S. Prasad, Useni Reddy Mallu A Bio analytical method development and validation

for simultaneous determination of Velpatasvir and Sofosbuvir in spiked human plasma, Asian Journal of

Chemistry; Vol.29, No. 11 (2017), 2565-2569

[16] Yadav, P. O. O. N. A. M., ANIL KUMAR Chauhan, and SATENDRA P. Singh. "α-l-rhamnosidase.

Sources, production, purification and characterization of the debittering enzyme." International Journal of

Biotechnology and Research 7.1 (2017): 2249-6858.

[17] Sunil Kumar Y.V., Mallu U.R., Kasi Viswanath I.V,RP-HPLC method development and cleaning method

validation for the analysis of Triclabendazole in veterinary pharmaceutical dosage forms 2016,

International Journal of ChemTech Research, 2016,9(5),507-520

[18] Phani R. S. Ch, Prasad K. R. S. and Useni R. M, HPLC Method Development, Validation, and Forced

Degradation for Simultaneous analysis of Oxycodone and Naltrexonein Pharmaceutical Dosage Form

Indian Drugs, 2019, 56 (2) 31-38

[19] MomoLokko, Christiana Naa, and Francis Lokko. "Clinical Presentation and Management of Human Ebola

Virus Disease in Sub-Saharan Africa." International Journal of Medicine and Pharmaceutical Science

(IJMPS) ISSN (P) (2016): 2250-0049.

[20] Ch J.R., Rao T B., Kumar Goud P S., Satish J., Rajashekhar K. Development and validation of liquid

chromatography method using the principles of QbD for antimalarialsused in Artemisinin based

combination therapy, Journal of Liquid Chromatography and Related Technologies, 2018,41(17-18),955-

963

[21] N.V.Krishna Reddy, Phani.R.S.Ch And R.Ramesh Raju RP-HPLC Method Development For Analysis

And Assay Of Donepezil In Formulation, PHARMANEST, Vol.1 (1) Sep-Oct-2010 100-103

[22] Nekkala K., Shanmukha Kumar J.V., Ramachandran D., Ramanaiah G. Development and validation of

stability indicating RP-LC method for estimation of Calcium Dobesilate in pharmaceutical formulations,

Der Pharmacia Lettre, 2016, 8(11) 236-242

[23] Addada R.R., Regalla V.R., Vajja M.R., Vema V.N., Anna V.R.A, concise stereo selective total synthesis

of decarestrictine J, Tetrahedron Letters, 2016 57 (35)3933-3935

[24] EM, Umoffia, et al. "Feeding Options and HIV Status of Babies Whose Mothers Were on Antiretroviral

Therapy in University of Teaching Hospital, Uyo, Nigeria." International Journal of Medicine and

Pharmaceutical Science (IJMPS) ISSN (P) (2016): 2250-0049.

[25] Phani R.S.Ch., Prasad K.R.A., UseniReddy. M,, High resolution RPHPLC method for the determination of

Nevirapine and associated impurities, Oriental Journal of Chemistry, 2016, 32, (2)1193-1203

[26] Athota R.V., Jagarlapudi S.K., Singampalli M.R. Stability indicating RP-HPLC method for

simultaneous assay of Bisoprolol and hydrochlorothiazide in combined tablet dosage form, International

Journal of PharmTech Research,2016, 9,(7), 329-339

[27] Hashemi, S. M. K., and H. K. Nadi. "Agricultural personnel's intrapreneurial behavior: effects of perceived

organizational support, psychological empowerment and entrepreneurial self efficacy." International

journal of agricultural science and research (IJASR) 2.1 (2012): 11-19.

[28] Phani R.S.CH., Mallu U.R., Prasad K.R.S., Mastnaiah T. Development and validation of an HPLC-UV

method for the determination of Raloxifene and related products (Impurities), Rasayan Journal of

Chemistry, 2016, 9(4),878-888

[29] Yelamanchi V S.K., Mallu U.R., Kasi Viswanath I.V., Balasubramanyam D., Murthy G.N.A newly

improved modified method development and validation of Bromofenac sodium sesquihydrate in bulk drug

manufacturing, 2016, Oriental Journal of Chemistry, 32(5) 2297-2315

[30] Sharma, E., and A. Kumar. "Identification and quantification of podophyllotoxin from

Podophyllumhexandrum by ESI-LC/MS/MS." Int. J. Appl. Phis. Biochem. Res 5 (2015): 1-8.

[31] SambasivaraoVattikuti and Phani. R.S.Ch Development Of Rapid Visible Spectrophotometric Methods For

The estimation Of Ranolazine In Formulations, IJRPC 2011, 1(1),66-72

[32] Phani.R.S.Ch, K.R.S. Prasad And Useni Reddy Mallu, High Resolution Rp-Hplc Method For The

Determination ofhypertensive Drug Products, Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 440 – 454

[33] Sambasivarao Vattikuti, Phani.R.S.Ch, R.Seetharaman, Dr.K.S.Lakshmi, Rp-Hplc Method Development

for Analysis of Deferasirox in Formulation, IJPI’s Journal of Analytical Chemistry Vol 1:4 (2011) 30-35

[34] Idris, Mohamed, et al. "Effect of temperature on partition behaviour and thermodynamic characteristics of

bioactive phenolics transfer in aqueous two-phase extraction system and evaluation of antimicrobial

activity." International Journal of Chemical & Petrochemical Technology 5: 1-8.

[35] NV. Krishnareddy, Phani R.S.Ch and R. Ramesh Raju New RP - HPLC Method Development for Analysis

and Assay of Lamivudine in Formulation, IJRPBS, Vol. 2 (1) Jan – Mar 2011,220-223

Downloads

Published

07.10.2020

How to Cite

Development and Validation of a New HPLC Bio Analytical Internal Standard Method for the Analysis of Two Immunology Drugs (Lamivudine and Dolutegravir) in Human Plasma. (2020). International Journal of Psychosocial Rehabilitation, 24(5), 3628-3637. https://doi.org/10.61841/529zhk75